| Filed On | Filing |
|---|---|
| 01 Mar 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 14 Nov 2022 |
8-K/A: Financial Statements and Exhibits
On July 20, 2022, Theravance Biopharma, Inc. (the “Company”) completed the sale of its 2,125 Class B Units and 6,375 Class C Units (collectively, the “Issuer II Units”) of Theravance Respiratory Company, LLC (“TRC”) to Royalty Pharma Inv... |
| 06 Dec 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 05 Oct 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 03 Jan 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 13 Oct 2015 | 8-K/A: Entry into a Material Definitive Agreement; Other Events |
| 28 Aug 2015 | 8-K/A: Results of Operations and Financial Condition |
| 24 Apr 2015 | 8-K/A: Entry into a Material Definitive Agreement |
Loading...
